Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substituted indanylacetic acids as PPAR-alpha-gamma activators.

Derek B Lowe1, Neil Bifulco, William H Bullock

  • 1Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA. derek.lowe@bayer.com

Bioorganic & Medicinal Chemistry Letters
|November 9, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxetane-to-azetidine skeletal editing.

Nature chemistry·2026
Same author

Advances in antimicrobial biomaterials for food packaging: A focus on food safety mechanisms and applications.

Food chemistry·2026
Same author

Harnessing nanotechnology: Transforming ocular drug delivery with advanced hydrogel systems.

Bioengineering & translational medicine·2026
Same author

Neuroanatomical and transcriptomic correlates of attention in schizophrenia.

Schizophrenia research. Cognition·2026
Same author

TACE-induced liver injury in hepatocellular carcinoma: mechanisms, prediction, and prevention in the era of gut microbiota and inflammasome research.

Clinics and research in hepatology and gastroenterology·2026
Same author

Metal-center electron affinity modulates multicolor electrochromism in 2D conjugated metal-organic frameworks.

Nature communications·2026

Researchers synthesized novel oxazole-substituted indanylacetic acids. These compounds function as ligands, interacting with various peroxisome proliferator-activated receptor (PPAR) nuclear receptor subtypes.

Area of Science:

  • Medicinal Chemistry
  • Molecular Pharmacology
  • Drug Discovery

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate gene expression.
  • PPAR subtypes (e.g., PPARα, PPARγ, PPARδ) play critical roles in metabolism, inflammation, and cell differentiation.
  • Dysregulation of PPARs is implicated in various diseases, including metabolic syndrome, diabetes, and cancer.

Purpose of the Study:

  • To synthesize and characterize a novel series of oxazole-substituted indanylacetic acid derivatives.
  • To evaluate the potential of these compounds as ligands for different PPAR nuclear receptor subtypes.
  • To explore the structure-activity relationships of these novel ligands.

Main Methods:

  • Chemical synthesis of oxazole-substituted indanylacetic acids.

Related Experiment Videos

  • In vitro binding assays to determine ligand affinity for PPARα, PPARγ, and PPARδ.
  • Reporter gene assays to assess the functional activity of the compounds as PPAR agonists or antagonists.

    • Main Results:

    • A series of oxazole-substituted indanylacetic acids were successfully synthesized.
    • The synthesized compounds exhibited varying degrees of binding affinity across PPAR subtypes.
    • Specific compounds demonstrated potent and selective activity towards certain PPAR nuclear receptor subtypes.

    Conclusions:

    • Oxazole-substituted indanylacetic acids represent a promising class of compounds for modulating PPAR activity.
    • These novel ligands offer potential for therapeutic intervention in diseases associated with PPAR dysregulation.
    • Further investigation is warranted to optimize lead compounds and explore their therapeutic applications.